首页> Cancer immunology research> Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.

Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Esther P M,Tjin

第一单位： Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands e.p.tjin@amc.uva.nl.

作者： Esther P M,Tjin ^[1] ; Gabrielle,Krebbers ^[2] ; Kimberley J,Meijlink ^[2] ; Willeke,van de Kasteele ^[2] ; Efraim H,Rosenberg ^[2] ; Joyce,Sanders ^[2] ; Petra M,Nederlof ^[2] ; Bart A,van de Wiel ^[2] ; John B A G,Haanen ^[3] ; Cornelis J M,Melief ^[2] ; Florry A,Vyth-Dreese ^[2] ; Rosalie M,Luiten ^[2]

作者单位： Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands e.p.tjin@amc.uva.nl. ^[1] Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands. ^[2] Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the NetherlandsAuthors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands. ^[3]

医学主题词成年人(Adult);老年人(Aged);癌症疫苗(Cancer Vaccines);女(雌)性(Female);GTP磷酸水解酶类(GTP Phosphohydrolases);粒细胞巨噬细胞集落刺激因子(Granulocyte-Macrophage Colony-Stimulating Factor);人类(Humans);免疫疗法(Immunotherapy);男(雄)性(Male);黑色素瘤(Melanoma);膜蛋白质类(Membrane Proteins);中年人(Middle Aged);突变(Mutation);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);皮肤肿瘤(Skin Neoplasms);T淋巴细胞(T-Lymphocytes);治疗结果(Treatment Outcome);肿瘤逃逸(Tumor Escape)

DOI 10.1158/2326-6066.CIR-13-0097

PMID 24894091

发布时间 2020-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Cancer immunology research

2014年2卷6期

538-46页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览3

点击下载本期目录封面

Cancer immunology research

2014年2卷6期

538-46页

检索历史清除

Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.

Cancer immunology research

相似文献

同项目论文

Cancer immunology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.

Cancer immunology research

相似文献

同项目论文

Cancer immunology research

相关期刊

检索历史清除